Replies to post #27573 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

(OOPS, hit the send button twice).
BVS, bottom line Celsion Corporation is an oncology drug development company that targets chemotherapeutic oncology drugs based on its heat-activated liposomal technology. Biocurex utilizes the RECAF marker, a cancer marker, which is used in blood tests to detect the presence of cancer in humans and animals. Biocurex has discovered this marker to be assciated with cancer cells of all types and has developed methods to not only detect cancer cells but just filed the patent recently to direct cancer therapeutic agents directly to the cancer cells w/o harming healthy cells or in other words whatever method utilized to destroy cancer those cells that do not possess the receptor associated w/ recaf will go unharmed. Recaf is only found and associated with cancer cells. It is a huge medical breakthrough. IMO big pharma was looking for this technology to emerge so they could direct their therapeutic agents to maximize its effect, whatever there magic bullet may be, and avoid any side effects by destroying any nearby healthy cells. The other MAJOR POINT made by Dr Moro is that many compounds could be hypothetically computer generated to play around with in order to find the most effective agent to destroy the cancer. He turned science fiction into reality. This is a recipe for BIG MONEY.

[Gold Seeker]

Opportunity stated: "Recaf is only found and associated with cancer cells."

Now, get control of yourself and stop the false information.

Explain why RECAF can be elevated in normal individuals?

Explain why RECAF will be elevated in benign tumors?

Explain why RECAF can be elevated with infections?

Don't believe the above is true? Read Moro's own words at oncopetdiagnostics.net.